Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry
September 27, 2024
September 27, 2024
CAMBRIDGE, Massachusetts, Sept. 27 -- Flagship Pioneering, a bioplatform innovation company, issued the following news release on Sept. 26, 2024:
* * *
Mirai's machine intelligence-based, open platform unlocks delivery to any tissue and cell type through rapid, iterative learning of in vivo tested chemistries
Co-optimization of cargo design and manufacturing ensure the best possible medicine and manufacturing strategy for each new program
Compa . . .
* * *
Mirai's machine intelligence-based, open platform unlocks delivery to any tissue and cell type through rapid, iterative learning of in vivo tested chemistries
Co-optimization of cargo design and manufacturing ensure the best possible medicine and manufacturing strategy for each new program
Compa . . .